|32.28|| +0.15 / +0.47%|
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. Pfizer was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.
|Ian C. Read||Chairman & Chief Executive Officer|
|Frank A. D'Amelio||Chief Financial Officer & EVP-Business Operations|
|Freda C. Lewis-Hall||Chief Medical Officer & Executive Vice President|
|Mikael Dolsten||President-Worldwide Research & Development|
|Ole Isacson||Chief Scientific Officer|